title: Oxidized phospholipids induce expression of human heme oxygenase-1 involving activation of cAMP-responsive element-binding protein.
abstract: Heme oxygenase-1 (HO-1) catalyzes the rate-limiting step in heme degradation, protects against oxidative stress, and shows potent anti-inflammatory effects. Oxidized phospholipids, which are generated during inflammation and apoptosis, modulate the inflammatory response by inducing the expression of several genes including HO-1. Here we investigated the signaling pathways and transcriptional events involved in the induction of HO-1 gene expression by oxidized 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine (OxPAPC) in human umbilical vein endothelial cells. OxPAPC up-regulated HO-1 mRNA and protein in a time- and concentration-dependent manner, whereas pro-inflammatory agents like TNF-alpha and lipopolysaccharide did not significantly induce HO-1 expression in human umbilical vein endothelial cells. Signaling pathways involved in the OxPAPC-mediated HO-1 induction included protein kinases A and C, as well as the mitogen-activated protein kinases p38 and ERK. The cAMP-responsive element-binding protein (CREB) was phosphorylated via these pathways in response to OxPAPC treatment and expression of a dominant-negative mutant of CREB inhibited OxPAPC-induced activity of a human heme oxygenase-1 promoter-driven luciferase reporter construct. We identified a cAMP-responsive element and a Maf recognition element to be involved in the transcriptional activation of the HO-1 promoter by OxPAPC. In gel shift assays we observed binding of CREB to the cAMP-responsive element after OxPAPC treatment. Induction of HO-1 expression by lipid oxidation products via CREB may represent a feedback mechanism to limit inflammation and associated tissue damage.
authors.affiliation: Department of Vascular Biology and Thrombosis Research, University of Vienna, Vienna A-1090, Austria.
authors.forename: Gerhard
authors.initials: G
authors.lastname: Krönke
authors.forename: Valery N
authors.initials: VN
authors.lastname: Bochkov
authors.forename: Joakim
authors.initials: J
authors.lastname: Huber
authors.forename: Florian
authors.initials: F
authors.lastname: Gruber
authors.forename: Stefan
authors.initials: S
authors.lastname: Blüml
authors.forename: Alexander
authors.initials: A
authors.lastname: Fürnkranz
authors.forename: Alexandra
authors.initials: A
authors.lastname: Kadl
authors.forename: Bernd R
authors.initials: BR
authors.lastname: Binder
authors.forename: Norbert
authors.initials: N
authors.lastname: Leitinger
mesh_terms: D017362:Cyclic AMP Response Element-Binding Protein / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D042783:Endothelial Cells / Q000378:metabolism; D005786:Gene Expression Regulation / Q000187:drug effects*; D006419:Heme Oxygenase (Decyclizing) / Q000096:biosynthesis*; D051547:Heme Oxygenase-1; D006801:Humans; D008565:Membrane Proteins; D010084:Oxidation-Reduction; D010743:Phospholipids / Q000494:pharmacology*; D010766:Phosphorylation / Q000187:drug effects; D011401:Promoter Regions, Genetic; D020218:Response Elements; D015398:Signal Transduction; D014471:Umbilical Veins / Q000166:cytology
chemical_list: D017362:Cyclic AMP Response Element-Binding Protein; D008565:Membrane Proteins; D010743:Phospholipids; C496541:HMOX1 protein, human; D006419:Heme Oxygenase (Decyclizing); D051547:Heme Oxygenase-1